Remdesivir close to EU's initial authorisation as COVID-19 treatment

The head of the European Union's medicines agency Guido Rasi said on Monday an initial authorisation for U.S. pharmaceutical company Gilead's remdesivir as a COVID-19 treatment could be granted in coming days.

from Reuters: Health News https://ift.tt/3dT4ina
via IFTTT